| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |